Lectins such as VVA-B4, which bind N-acetylgalactosaminyl (GalNAc)-terminated saccharides, selectively stain the neuromuscular junction, thus defining a synapse-specific carbohydrate. In seeking roles for this carbohydrate, we asked whether VVA-B4 affected the distribution of acetylcholine receptors (AChRs) on cultured muscle cells. We found that incubation of myotubes with VVA-B4 induced formation of AChR clusters and potentiated the effect of a nerve-derived clustering factor, agrin. Additional experiments implicated GalNAc-terminated glycoconjugates as modulators of agrin-induced AChR clustering. Enzymatic removal of GalNAc residues or treatment with a multivalent protein-GalNAc conjugate blocked agrin-induced clustering, whereas enzymatic unmasking of additional GalNAc residues induced clustering in the absence of added agrin. Moreover, incubation with agrin led to redistribution of VVA-B4-binding material on myotubes. Together, these results suggest that agrininduced clustering of AChRs involves a GalNAcdependent step.
Introduction
Cell surface carbohydrates are likely to play important roles in the developing nervous system (Margolis and Margolis, 1989; Jessell et al., 1990) . The enormous diversity of glycoconjugate structures found in neural tissue, the striking spatiotemporal specificity of their expression patterns, and the strong evidence for carbohydrate-mediated recognition and targeting processes in nonneural tissues all favor this idea (Lasky, 1992; Drickamer and Taylor, 1993; Feizi, 1993) . Moreover, carbohydrates have been implicated as mediators of adhesive interactions among neural cells (e.g., Acheson et al., 1991; . Here, we provide evidence that saccharides are involved in synaptogenesis.
We showed previously that lectins specific for N-acetylgalactosaminyl (GalNAc)-terminated saccharides selectively stain neuromuscular junctions in skeletal muscle, thereby defining a synapse-specific carbohydrate (Sanes and Cheney, 1982 ; see also Ribera et al., 1987; (~rne-Finderle and Sketelj, 1993) . In contrast, lectins with other specificities stain synaptic and extrasynaptic portions of the muscle fiber surface with similar intensities, indicating that there is no overall excess of carbohydrate at the synapse (Sanes and Cheney, 1982) . Further studies showed that the synaptic carbohydrate is associated with at least three glycoconjugates that are concentrated at synaptic sites: acetylcholinesterase in the synaptic basal lamina, a GM2-1ike glycolipid in the postsynaptic membrane, and an unidentified moiety in the presynaptic nerve terminal (Scott et al., 1988 (Scott et al., , 1990 . Interestingly, whereas interspecific and even interstrain variations in glycosylation patterns are common (e.g. Fox et al., 1982; HolthSfer, 1983; Ponder et al., 1985) , the synaptic carbohydrate is phylogenetically conserved; GalNac-specific lectins selectively stain neuromuscular junctions in mammals, birds, fish, reptiles, and amphibians (Scott et al., 1988) . Moreover, a GalNAc transferase is itself concentrated at neuromuscular junctions, and its expression is regulated by synaptic interactions (Scott et at., 1990) .
The phylogenetic conservation of the synaptic carbohydrate, its association with several molecules, and the neural control of its expression all suggest that GalNActerminated sugars play a role at the neuromuscular junction, but none has been demonstrated to date. To initiate functional studies, we used cells of a mouse myogenic line, C2 (Yaffe and Saxel, 1977; Blau et al., 1985) . C2 myotubes assemble high density aggregates of AChRs, sometimes called hot spots, many of which are associated with cytoskeletal and basal lamina components that are also synapse associated in vivo (Silberstein et al., 1982; Inestrosa et al., 1983; Gordon et al., 1993) . Some hot spots form spontaneously, but their number can be increased by innervation or incubation with soluble neural extracts (Gordon et al., 1993) , making C2 cells convenient for studying some aspects of postsynaptic differentiation. We found that a G alNAc-specific lectin, Vicia Villosa agglutinin B4 (VVA-B4), selectively stained AChR-rich portions of the myotube surface, demonstrating that GalNAc-terminated glycoconjugates (VVA-B4 receptors [VVARs] ) are coclustered with AChRs. Based on this result, we asked whether VVA-B4, GalNAc-protein conjugates, or GalNAc-degrading enzymes could affect the formation of AChR clusters. In particular, we focused on the clustering induced by agrin, a nerve-derived protein that is believed to induce differentiation of the postsynaptic membrane in vivo (McMahan, 1990; McMahan et al., 1992; Campanelli et al., 1992; Nastuk and Fallon, 1993) and has been shown to promote AChR clustering in C2 myotubes (Ferns et al., , 1993 . Our results implicate VVARs in the control of AChR clustering and raise the possibility that agrin acts through a GalNAc-dependent mechanism.
Results

VVARS Are Concentrated at AChR-Rich Hot Spots
We began this study by assessing the distribution of VVARs on C2 myotubes. C2 myoblasts were grown in rich medium until they were almost confluent, then switched to a serum-poor medium to inhibit further proliferation and induce formation of myotubes. Three to four days after fusion was initiated, cultures were double-labeled with rhodamine-(~-bungarotoxin to stain AChRs and fluorescein-VVA-B4 to stain GalNac-terminated glycoconjugates. As shown in Figure 1 , VVA-B4 selectively stained AChR clusters. In addition, a low level of VVA-B4 staining was sometimes seen along the remainder of the myotube and in the extracellular matrix (Figures l a and lc) . Myoblasts probably contributed some of these diffuse VVARs; VVA-B4 intensely stained the matrix secreted by proliferating myoblasts (Figure le) , and matrix was most intensely stained in areas of myotube cultures that were especially cell dense and/or contained accumulations of unfused mononucleated cells. In contrast, the selective staining of AChR clusters by VVA-B4 was consistent and striking; 75% of intenselyVVA-B4-stained clusters corresponded to AChR clusters, and -80% of the AChR clusters corresponded to focal accumulations of VVARs. Moreover, most, if not all, AChR clusters were stained by VVA-B4 to some extent. Labeling by VVA-B4 was eliminated by inclusion of 20 mM GalNAc in the staining solution (Figure c2 myotubes were incubated with '2Sl-labeled (~-bungarotoxin, then AChRs were solubilized as described in Experimental Procedures. Aliquots of the extract were incubated with underivatized agarose, VVA-B4 agarose, or ConA-agarose; following incubation, the agarose was pelleted. The pellet and cleared extract were then counted.
ld), whereas inclusion of 20 mM galactose was without effect (data not shown). Thus, carbohydrates that resemble or contain GalNac termini, VVARs, are concentrated at AChR-rich domains in vitro as they are in vivo.
A simple explanation for the colocalization of AChRs and VVARs would be that AChRs are VVARs. However, two observations indicate that this is not the case. First, within the boundaries of hot spots, patterns of VVA-B4 and a-bungarotoxin staining differed (Figures l b and lc) . Second, AChRs that had been labeled with 12Sl-labeled (x-bungarotoxin were not precipitated by VVA-B4-agarose in conditions under which they were efficiently precipitated by agarose conjugated to a mannose-specific lectin, concanavalin A (Table 1) .
VVA-B4 Induces AChR Clustering
To ask whether VVARs were involved in AChR clustering, we added 50 i~g/ml VVA-B4 to the culture medium 2 days after initiation of fusion, a time at which many myotubes but few hot spots had formed. After 18 hr, cultures were stained with rhodamine-a-bungarotoxin and examined with phase and fluorescence optics. VVA-B4 had no apparent effect on the number or morphology of myotubes (data not shown), but its addition led to an increase in the number of AChR clusters (Figures 2a and 2b) . The effect was seen in numerous experiments, but its magnitude varied considerably among experiments. For example, the effect was insignificant in the experiment shown in Table 2 but greater than 2-fold in the experiment shown in Table 3 . In general, VVA-B4 appeared to be most effective on myotubes that already had the highest levels of hot spots in the absence of VVA-B4. Knowing this, we tested VVA-B4 on myotubes that had been treated with soluble extracts made from rat brain or chick embryos, both of which have been shown to contain components that induce AChR All compounds listed were added to C2 myotubes for 24 hr prior to analysis. Chick embryo extract was added at 0.02 embryo equivalent per milliliter. Rat brain extract was added at 2.5% (w/v). Recombinant C-terminal agrin was added at 10 ng/ml. N-acetylgalactosamine (GalNAc) and galactose (Gal) were added at 20 raM. VVA-B4 was added at 50 ilg/ml. Values are means _+ SEM, n = 7-12.
clustering (Christian et al., 1978; Salpeter et al., 1982; Sanes et al., 1984; Olek et al., 1988) . Under these conditions, VVA-B4 increased AChR clustering dramatically and reproducibly ( Table 2 ). The effect of VVA-B4 was GalNAc mediated, in that it was blocked by addition of GalNAc to the incubation medium (Table 2 ) and mimicked by each of three other lectins that recognize GalNAc-terminated glycoconjugates and selectively stain neuromuscular junctions (Table 3 ). In contrast, other sugars (galactose and glucose; data not shown) and lectins with other specificities (Table 3) were inert. Thus, GalNAc-like glycoconjugates modulate clustering of AChRs. Because VVA-B4 binds to myoblasts and extracellular matrix, as well as to myotube surfaces (see Figure 1) , it was not clear where the VVARs that stimulated AChR clustering were localized. To study this point, we incubated cultures with VVA-B4 that had been immobilized on agarose beads. AChR clusters formed on portions of the myotube surface that were contacted by VVA-B4-agarose ( Figure 2e ). In contrast, heparin-agarose, wheat germ agglutinin-agarose, GalNAc-agarose, and underivatized agarose did not induce clustering ( Figure 2f ; data not shown). Thus, VVA-B, induces AChR clustering by a local interaction with VVARs on the myotube surface.
VVA-B4 Potentiates the Clustering Activity of Agrin
During synapse formation, motor axons induce clustering of AChRs at sites of nerve-muscle contact, presumably by releasing a factor that acts locally (Hall and Sanes, 1993) . Several lines of evidence suggest that this factor is agrin, a cluster-promoting protein that is produced by motor neurons, transported to nerve terminals, secreted, and incorporated into the basal lamina of the synaptic cleft (McMahan, 1990 Campanelli et al., 1992; Reist et al., 1992; Nastu k and Fallon, 1993) . Accordingly, we asked whether VVA-B4 could affect the clustering activity of agrin. As reported previously (Ferns et al., 1993) , an affinitypurified recombinant C-terminal fragment of agrin (provided by J. Campanelli and R. Scheller, Stanford University) was a potent promoter of AChR clustering on C2 myotubes, exerting a stronger effect than the highest concentrations of VVA-B4 tested ( Figure 2c ). However, addition of VVA-B, potentiated the effect of agrin ( Figure 2d ; Table 2 ). In some experiments, it appeared that AChR clusters induced by agrin plus VVA-B4 were smaller than those induced by either agent on its own ( Figure 2d) ; however, this effect was not reproducible. As with VVA-B, alone, VVA-B4-induced potentiation of the effect of agrin was blocked by GalNAc, but not by galactose, and was Lectins were added to C2 myotubes for 6 hr at a concentration of 50 p~g/ml. Recombinant C-terminal agrin was added at a concentration of 10ng/ ml. VVA-B4, Vicia villosa agglutinin isolectin 134; DBA, Dolichos biflorus agglutinin; SBA, soybean agglutinin; WFA, Wisteria floribunda agglutinin; WGA, wheat germ agglutinin; PNA, peanut agglutinin; GalNAc, N-acetylgalactosamine; Gal, galactose; Man, mannose; GIc, glucose; GIcNAc, N-acetylglucosamine; SA, sialic acid. Data on staining of synaptic and extrasynaptic portions of the muscle fiber surface are from Scott et aL (1988) . Values are means 4-SEM, n = 9-16. Figure 3. Comparison of VVA-B4-and AgrinInduced AChR Clustering (a) Myotubes were treated for 18 hr with or without 10 ng/ml agrin, after which varying concentrations of VVA-B4 were added for an additional 6hr.
(b) Myotubes were treated with 10 ng/ml agrin for 18 hr, after which VVA-B4 was added at 50 p~g/ml for the times shown.
(c) Myotubes were incubated in 10 ng/ml agrin for 18 hr, Cells were then washed three times in fusion medium, and 50 I~g/ml VVA-B, was added for the times indicated. For the data marked "Pre-Label," the cells were labeled with rhodamine-a-bungaretoxin during the final hour of the incubation with agrin. For the cells marked "Post-Label," rhodamine-~-bungarotoxin was added for the final hour of the incubation with VVA-B,.
(d) Myotubes were incubated with fusion medium (control), 50 Ilg/ml VVA-B4, 10 ng/ml agrin, or 50 i~g/ml VVA-B4 and 10 ng/ml agrin. For the final 3 hr of this incubation, the cells were labeled with 5 nM l~l-labeled ~-bungarotoxin. The cells were then washed 4 times in PBS, and AChRs were solubilized in lysis buffer containing lO/0 Triton X-100. The total radioactivity solubilized under each condition was compared. Values are mean _+ SD; n = 6-12.
mimicked by GalNAc-specific lectins, but not by lectins with other specificities (Table 2 and Table 3 ). (Wheat germ agglutinin, which binds sialic acid and N-acetylglucosamine, inhibited agrin-induced AChR clustering, possibly because it inhibits agrin binding to muscle cells; Ma et al., 1993.) In a series of assays, we compared the effects of VVA-B4 and agrin and characterized their interaction. VVA-B4 induced AChR clustering with a half-maximal concentration of about 5 ~g/ml (-30 nM) both in the presence and the absence of agrin (Figure 3a) . AChR clusters were induced quickly by both agents, being maximal 4-8 hr after addition of VVA-B4 in the presence of agrin (Figure 3b ) and 6-8 hr after addition of agrin in the absence of VVA-B4 (Godfrey et al., 1984; Wallace, 1988; see below) . As previously reported for agrin (Godfrey et al., 1984; Wallace, 1988) , VVA-B, promoted aggregation of AChRs that were already on the cell surface before the lectin was added, as shown by comparing myotubes labeled with rhodamine-~-bungarotoxin before or after addition of VVA-B4 (Figure 3c ). Moreover, both agents promoted clustering without detectably increasing surface-associated AChRs, as shown by labeling treated and untreated cultures with 1251-labeled ~-bungarotoxin (Figure 3d ). Consistent with its effect on preexisting receptors, VVA-B4, like agrin (Wallace, 1988) , clustered AChRs in the presence of cycloheximide, an inhibitor of protein synthesis (data not shown).
VVA-B4 might potentiate the effect of agrin by binding directly to it. To test this possibility, we preincubated an aliquot of agrin with a 1000-fold excess of VVA-B4-agarose, then pelleted the agarose and added the supernatant to C2 myotubes. Agrin was just as effective at clustering under these conditions (68 _.+ 9 clusters per field; mean _.+ SEM) as if it had not been treated with VVA-B4-agarose (57 ___ 3 clusters per field), indicating that agrin is not a VVAR. We also asked whether agrin bound directly to GalNAc by incubating agrin with GalNAc-agarose, then pelleting the agarose and testing the supernatant. Again, no loss of agrin activity was detected (data not shown).
Agrin Induces Redistribution of VVARs
To gain further insight into the relationship of VVARs to agrin, we stained agrin-treated myotubes with fluorescein-VVA-B4 and compared them with cells that had not been exposed to agrin. As shown in Figure 4 , agrin led to two striking alterations in the distribution of VVARs on the myotube surface. First, agrin induced formation of new high density clusters of VVARs; as expected, these clusters corresponded to AChR-rich hot spots. Second, some segments of agrin-treated myotubes and deposits of extracellular matrix were brightly and diffusely stained by VVA-B4. To learn whether AChR clustering preceded or followed VVAR redistribution, cultures were fixed and stained 2, 4, 6, 8, and 24 hr after addition of agrin. No marked redistribution of either component occurred within 2 hr, but by 4 hr, AChR clustering and increases in clustered, diffuse, and matrix-associated VVARs were all apparent (Figure 4b ). Generally, diffuse and matrix-associated VVARs were associated with groups of AChR clusters. For example, 24 hr after agrin addition, individual cultures contained some areas in which agrin had exerted little effect (Figure 4c ) and other areas in which the effect of agrin had been dramatic ( Figure 4d) ; little diffuse VVA-B4 staining was apparent in regions of low AChR clustering (Figure 4c' ), whereas VVA-B4 staining was dramatically increased in cluster-rich areas (Figure 4d') . Thus, the 
Agrin-lnduced AChR Clustering Is GalNAc Dependent
The effects of agrin on the distribution of VVARs and AChRs raised the possibility that agrin-induced AChR clustering might involve a GalNAc-dependent step. We tested this possibility in three ways. First, we removed VVARs from the cell surface by adding ~-N-acetylhexosaminidase to the cells during agrin treatment. A 13-specific rather than an o-specific enzyme was used because synaptic VVARs are in the 13 form (Scott et al., 1988) . However, this enzyme removes both GalNAc and N-acetylglucosamine residues. Treatment with ~-N-acetylhexosaminidase removed VVARs from the cell surface, inhibited agrin-induced AChR clustering, and prevented agrininduced VVAR redistribution (Table 4 ; compare Figure 5a with Figure 4b ). I~-N-acetylhexosaminidase from each of two sources (jack bean and bovine epididymis) had similar effects, whereas neither of two enzymes that modify widely distributed cell surface carbohydrates, 13-galactosidase and sulfatase, affected the ability of agrin to induce AChR clusters (Table 4) . I~-N-acetylhexosaminidase led to rapid dispersal of clusters when it was added following pretreatmerit with agrin, indicating that the targets of enzyme action were associated with the cells rather than with the agrin (data not shown), To test the possibility that the 13-N-acetylhexosaminidase treatment had a direct effect on AChRs, we tested it on fibroblasts that had been transfected with cDNAs encoding the ~, 13, ~', and ,5 AChR subunits. Such cells express functional AChRs diffusely on their surface, but further addition of the 43K AChRassociated cytoskeletal protein induces the formation of small AChR clusters (Phillips et al., 1991 (Phillips et al., , 1993 . Addition of VVA-B4 had no effect on AChR distribution (data not Compounds were added to C2 myotubes for 6 hours. Enzyme sources and amounts were as follows: 0.1 U neuraminidase from Clostridium perfringens; 0.5 U J~-N-acetylhexosaminidase 1 from Jack Bean; 0.05 U I~-N-acetylhexosaminidase type A from bovine epididymis; 0.05 U 13-N-acetylhexosaminidase type B from bovine epididymis; 10 U sulfatase from Helix pomatia; 10 U I~-galactosidase from E. coll. VVA-B4 was added at 50 p.g/ml and agrin (where indicated) at 10 ng/ml. Values are means +_ SEM; n = 10-20 measurements. shown), and addition of 13-N-acetylhexosaminidase had no effect on 43K-induced AChR clustering (Figures 5c and  5d ). Thus, agrin-dependent clustering of AChRs on myotubes requires N-acetylhexosaminyl-terminated glycoconjugates, but 43K-dependent clustering in nonmuscle cells does not. Second, we asked whether an agrin-independent increase in cell surface VVARs could induce AChR clustering. Neuraminidase treatment of many tissues increases staining by GalNac-specific lectins, presumably because many GaINAc residues are normally masked by sialic acid (e.g., Laitinen et al., 1989) . Likewise, extrasynaptic portions of the muscle fiber surface, which are normally VVA-B4 negative, become VVA-B4 positive following neuraminidase treatment of muscle sections (Iglesias et al., 1992; L. Scott, unpublished data) . Based on these results, we incubated live C2 myotubes with neuraminidase, then stained them with rhodamine-a-bungarotoxin and fluorescein-VVA-B4. Neuraminidase treatment led to an increase in the intensity of staining by VVA-B4 (Figure 5b~ and to a -10-fold increase in the number of AChR clusters per myotube (Table 4 ). This treatment did not affect AChR levels on the cell surface (measured with 12~l-labeled bungarotoxin; data not shown), indicating that clustering was not an indirect effect of increased AChR expression. Neuraminidase was equally effective in serum-containing and serum-free medium, indicating that the enzyme promoted clustering via its action on muscle, rather than by unmasking a latent clustering factor in serum (data not shown). Neuraminidase did not induce formation of AChR clusters on AChR-transfected fibroblasts (Figure 5e and 5f). Thus, enzymatic generation of new VVARs leads to agrin-independent AChR clustering on myotubes but not on nonmuscle cells.
Finally, we tested soluble GalNAc-containing compounds as inhibitors of agrin. Although GalNAc itself did not block agrin-induced AChR clustering (see Table 2 ), we were aware that many mammalian lectins show a marked preference for multivalent sugars (Lee and Lee, 1994) . Therefore, in the hopes of increasing the avidity of a puta- tive GalNAc-binding protein for its ligand, we tested a bovine serum albumin (BSA)-GalNAc conjugate, prepared at a nominal ratio of 15-20 GalNAc residues per molecule of BSA. BSA-GalNAc blocked agrin-induced clustering of AChRs almost completely at 50 pg/ml, whereas BSA-N-acetylglucosamine, BSA-glucose, and BSA alone were inert at 10-fold higher concentrations (Figure 6a ). One plausible explanation for this result (see Discussion)is that there is an endogenous GalNAc-selective lectin in muscle that is involved in AChR clustering. Interestingly, in the presence of BSA-GalNac, agrin induced formation of very small AChR-rich patches (Figure 6b ), which were clearly distinguishable from hot spots and were seldom observed on untreated myotubes.
Detection of VVA-B4-Binding Proteins in C2 Cell Membranes
To understand how GalNAc-like carbohydrates affect AChR clustering, it will be necessarY to identify the bioactive VVARs of C2 cells. As a first step toward this goal, we prepared lysates or membranes from C2 myotubes, fractionated them by gel electrophoresis, transferred them to nitrocellulose membranes, and probed the membranes with biotinylated VVAoB4. As shown in the first lane of Figure 7 , VVA-B4 bound to at least 15 distinct glycoproteins in the membrane-enriched fraction. A similar pattern was observed when whole-cell lysates were probed (data not shown). Binding to all but a few of the bands is specific, in that it was abolished by addition of 20 mM GalNAc to the lectin solution ( Figure 7 , lane 3). No differences were detected between control myotubes and myotubes that had been treated with agrin for 24 hr before harvesting (Figure 7, lanes 1 and 2) . Recent reports from four laboratories have identified a dystrophin-associated glycoprotein, ~-dystroglycan, as a major agrin-binding component of muscle cells (Bowe et al., 1994; Gee et al., 1994; Campanelli et al., 1994; Sugiyama et al., 1994) . To ask whether a-dystroglycan is a VVAR, we probed adjacent lanes from a gel with VVA-B4 and an antiserum to a-dystroglycan (Ibraghimov-Beskrovnaya et al., 1992) . No prominent VVA-B4-reactive bands comigrated with ~-dystroglycan (arrow in Figure 7 ). This result is consistent with those of Ervasti and Campbell (1991) , who previously reported that hexosaminidase has no detectable effect on the electrophoretic mobility of rabbit muscle dystroglycan. Thus, we obtained no evidence that ~-dystroglycan is a VVAR, although we cannot claim to have ruled out this possibility. VVA-B4 activates GalNAc-terminated glycoconjugates (VVA-B4), leading to formation of AChR clusters. As detailed in the Discussion, agrin could increase the level of VVARs (1), activate VVARs (2), bind to VVARs (3), or act synergistically with VVARs (4).
Discussion
Carbohydrates that contain or resemble terminal GalNAc residues are concentrated at the neuromuscular junction in vivo (Sanes and Cheney, 1982; Scott et al., 1988) and at nerve-induced (Sanes and Cheney, 1982) and spontaneously occurring (see Figure 1 ) AChR clusters in vitro. In seeking roles for this synapse-associated carbohydrate, we discovered that the GalNAc-specific lectin, VVA-B4, can induce AChR clustering. We propose that VVA-B4 induces clustering by binding to GalNAc-terminated glycoconjugates (VVARs) because it is inhibited by soluble GalNAc (see Table 2 ) and mimicked by other GalNAcspecific lectins (see Table 3 ). The relevant VVARs appear to be associated with the myotube surface and to act locally, since VVA-B4-agarose beads induce clusters at points of contact with myotubes (see Figure 2) . Since VVA-B4 has no known enzymatic activity, activation of VVARs could result from occupancy per se or from cross-linking by the multivalent lectin tetramer (Tollefsen and Kornfeld, 1983) . These results support the suggestion (Scott et al., 1988) that the GalNAc-terminated glycoconjugates play a role in directing the localization of synaptic components.
Additional experiments showed that VVA-B4 can potentiate the AChR clustering induced by agrin. Numerous agents are capable of inducing AChR clusters on cultured myotubes, including tissue extracts, extracellular matrix components, growth factors, and even latex beads (Hall and Sanes, 1993) . Some of these agents may act in ways that are of little biological significance. However, several observations suggest that VVARs may be part of the pathway by which agrin, the best-characterized clustering agent, acts. First, agrin leads to a rapid redistribution of myotube-associated VVARs (see Figure 4) . Second, treatment of myotubes with ~-N-acetylhexosaminidase, which removes VVARs from the cell surface, inhibits the activity of agrin (see Table 4 ). Third, treatment of myotubes with neuraminidase, which increases the density of VVARs on myotubes, mimics the effect of agrin (see Table 4 ). Finally, a GalNAc-protein conjugate (GalNAc-BSA) inhibits agrin (see Figure 6 ). Together, these results suggest that agrininduced AChR clustering is GalNAc dependent.
In considering how VVA-B4 might act, two questions are particularly pertinent; is there an endogenous VVA-B4-1ike molecule, and how does agrin interact with VVARs? With respect to the first of these issues, it is possible that VVA-B4 activates molecules that happen to bear GalNAc residues but normally interact with carbohydrate-independent ligands. Many precedents for such an interaction are known. For example, antibodies to the insulin receptor can cross-link insulin receptors and thereby mimic the effects of insulin (Kahn et al., 1978) ; plant lectins can crosslink glycoproteins on lymphocytes and thereby activate immune responses (Brown and Hunt, 1978) . In neither of these cases is the experimental perturbant structurally related to the endogenous ligand. On the other hand, two sets of observations favor the possibility that there is an endogenous GalNAc-binding molecule. First are the results that motivated the present study, that multiple GalNAc-terminated glycoconjugates are concentrated at neuromuscular junctions of numerous vertebrate species (see Introduction). This pattern of expression suggests that the GalNAc-terminated carbohydrate is itself important. Second, the ability of GalNAc-protein conjugates to inhibit agrin-induced clustering suggests that GalNAc itself, rather than only the molecule to which it is attached, is involved in the clustering process. In this context, it is worth noting that a GalNAc-inhibitable lectin has been isolated from avian muscle (Ceri et al., 1981; Ceri and Roberts, 1985) . Interestingly, although GalNAc selectively inhibits this lectin, the apparent affinity of the interaction is low, a property that could explain why GalNAc-BSA (which is multivalent) can inhibit agrin but GalNAc itself cannot (see Lee and Lee, 1994) .
As to the interaction of agrin with VVARs, we can envision four possibilities (Figure 8 ). First, agrin might promote formation of cell surface VVARs. For example, agrin could increase the amount of the glycoconjugate (e.g., by activating a GalNAc transferase); it could unmask GalNAc residues (e.g., by activating a neuraminidase); or it could lead to externalization of intracellular glycoconjugates (e.g., as insulin does for glucose transporters; Mueckler, 1994) . In favor of this class of mechanism is the observation that neuraminidase induces AChR clustering in the absence of agrin.
Second, agrin could lead to activation of preexisting cell surface VVARs, for example, via effects on the cytoskeleton or via activation of a kinase (Wallace, 1992) . We have no evidence for or against this possibility.
Third, the binding of agrin to its receptor might be GalNAc dependent. A precedent for this model is provided by basic fibroblast growth factor, which must bind both to a glycoconjugate (heparan sulphate proteoglycan) and to a membrane-associated receptor tyrosine kinase to activate the kinase and thereby transduce a signal to the interior of the cell (Rapraeger et al., 1991 ; Yayon et al., 1991) . It is also possible that the signal-transducing agrin receptor is itself a VVAR, although we have been unable to show that the only agrin-binding protein identified to date, a-dystroglycan, bears terminal GalNAc residues (see Figure 7 ; see also Ervasti and Campbell, 1991) . In this scheme, it is not clear why VVA-B4 would potentiate the effect of agrin. However, since differences in efficacy have been documented between soluble, truncated forms of agrin (such as the C-terminal fragment we used here) and full-length, cell-associated forms (Ferns et al., 1993) , it is possible that VVA-B4 can mimic or replace a sugar-binding activity that is normally mediated by the N-terminal fragment of agrin or by an agrin-associated protein.
Finally, agrin and VVARs might act through separate pathways, with activation of the GalNAc-dependent mechanism being necessary for optimal induction of AChR clustering by agrin. In this case, one might imagine that normally occurring levels of VVARs are sufficient to support some activation by agrin but are rate limiting. Thus, alterations in the level or aggregation state of VVARs would affect the extent of cluster formation in either the absence or presence of agrin. Our current efforts focus on testing these and other possibilities by identifying those VVARs, among the many present in C2 cells, that affect AChR clustering.
Experimental Procedures
Cell Culture The C2C12 subclone of the C2 cell line was obtained from ATCC (Bethesda, MD) and grown on gelatin-coated dishes in Dulbecco's modified Eagle's medium (DMEM) supplemented with penicillin, streptomycin, and 20% fetal calf serum. For histological studies, cells were trypsinized and replated on gelatin-coated 12 mm circular glass coverslips, grown to confluence, and induced to fuse by transfer to DMEM containing 2% horse serum with penicillin and streptomycin. Cells were switched to fusion medium 3-4 days prior to treatment with one or more of the following: lectins (Sigma Chemicals, St. Louis, MO; see Table 3 ), rat brain extract (Sanes et al., 1984) , chick embryo extract, affinity-purified recombinant C-terminal fragment of agrin (the generous gift of J. Campanelli and R. Scheller, Stanford University; Ferns et al., 1993), BSA-sugar conjugates (Sigma and Biocarb, Lund, Sweden), and sugar hydrolyzing enzymes (Sigma; see Table 4 ). The BSAsugar conjugates were washed in a 10,000 molecular weight filter (Millipore) with 16 volumes of distilled water prior to usage.
Fibroblasts stably transfected with AChR subunit cDNAs (QF18 cells; Phillips et al., 1991 ; gift of John Merlie) were grown in Earle's 199 with 5% fetal calf serum, 10% tryptose phosphate broth, 1% dimethylsulfoxide, penicillin, and streptomycin. Cells were transfected with pRSVM43, which encodes 43K, as described by Maimone and Merlie (1993) .
Fluorescence Microscopy
AChRs were labeled by incubating live cells for 1 hr with 50 ng/ml monovalent rhodamine-~-bungarotoxin (gift of Jeff Lichtman or purchased from Molecular Probes, Eugene, OR). The cells were then washed in phosphate-buffered saline (PBS), fixed for 20 min in 1% paraformaldehyde in PBS, rinsed with PBS, and then washed with PBS containing 10% goat serum. To label VVARs, the fixed and washed cells were incubated with 5 pg/ml fluorescein-conjugated VVA-B4 (Sigma) for 30 min in PBS with 10% goat serum, then washed for 30 min. AChR clusters were then viewed with a 40 x oil-immersion objective counted in 10-20 visual fields per covers,p, with at least 2 coverslips counted per treatment. AChR-rich areas />5 I~m in length were counted as clusters. When the extent of clustering was especially variable, more fields were counted until a standard error ~< 10% of the mean was achieved.
Lectin Precipitation of AChRs
Live cells were labeled with 5 nM ~2~l-labeled bungarotoxin (monovalent) for 3 hr at 37°C, then washed 4 times with PBS. The cells were then lysed in ice cold lysis buffer containing PBS with 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1% Triton X-100. After solubilization, the lysate was spun for 3 min at 15,000 x g. The supernatant was transferred to tubes containing enough VVA-B4-agarose or ConAagarose to bind 10 I~g of sugar and incubated for 18 hr with gentle shaking at 4°C. In some experiments, 1 mM CaCI2 was added to the incubation solution to maximize activity of VVA-B4. Following incubation, the agarose was centrifuged for 1 min at 15000 x g and the supernatant removed and counted in a gamma counter. The pellet was then washed three times in lysis buffer and counted. The binding capacity of VVA-B4-agarose was confirmed by incubation with (and precipitation of) BSA-GaINAc (Sigma).
Lectin Blotting
C2 myotubes were grown on 15 cm diameter dishes and harvested in reducing SDS gel buffer to prepare whole-cell lysates. Alternatively, a membrane-rich fraction was prepared from the cells. For this purpose, C2 myotubes were washed with PBS, then the following buffer was added: 50 mM Tris (pH 7.0), 2 m M EDTA, 2 mM phenylmethylsulfonyl fluoride, 10 ~tg/ml leupeptin, 20 I~g/ml aprotinin, and 20 p,g/ml chicken trypsin inhibitor (Sigma). Cells were then lysed using 20 strokes of a Dounce homogenizer. Unbroken cells and nuclei were removed by pelleting at 2000 x g for 3 min. The supernatant was centrifuged at 100,000 x g for 1 hr, and the resulting membrane pellet was solubilized by boiling in reducing SDS gel buffer.
Proteins were separated by reducing polyacrylamide gel electrophoresis on 10% acrylamide gels. Proteins were transferred to nitrocellulose overnight in 50 mM Tris (pH 8.8), 380 mM glycine, 0.10/0 SDS, and 20% methanol. The nitrocellulose was blocked in buffer containing 10 mM Tris (pH 8.0), 150 mM NaCI, 0.2 mM EDTA, 0.1% Tween 20, and 1 mg/ml BSA. Membranes were incubated with biotinylated VVA-B4 at a concentration of 5 I~g/ml with or without 20 mM GalNAc, washed, and incubated with alkaline phosphatase-coupled streptavidin (Boehringer Mannheim). An adjacent lane was blotted with antiserum FP-D, which recognizes c~-dystroglycan (Ibraghimov-Beskrovnaya et al., 1992) , followed by alkaline-phosphatase-coupled donkey-m-sheep secondary antibody (Sigma). Blots were developed using 5-bromo-4-chloro-3-indolyl phosphate as substrate.
